To survey the efficacy and safety of dual therapy with daclatasvir and asunaprevir in the elderly hepatitis C virus (HCV) patients multicentricity. METHODSInterferon-ineligible/intolerant patients and non-responders t...
详细信息
To survey the efficacy and safety of dual therapy with daclatasvir and asunaprevir in the elderly hepatitis C virus (HCV) patients multicentricity. METHODSInterferon-ineligible/intolerant patients and non-responders to previous pegylated-interferon/ribavirin therapy with chronic HCV genotype 1b infection were enrolled. Child B, C cirrhotic patients were excluded. Patients received oral direct acting antiviral treatment consisting of 60 mg daclatasvir once daily plus 200 mg asunaprevir twice daily for 24 wk. We divided the patients into two groups of 56 elderly patients (≥ 75 years-old) and 141 non-elderly patients (24). In the former, 1.8% experienced viral breakthrough, as compared with 3.5% in the latter (not significant). Adverse events occurred in 55.4% of the former and 56.0% of the latter. In the former, 7 cases (12.5%) were discontinued due to adverse events, and in the latter 9 cases were discontinued (6.4%, not significant). CONCLUSIONDual therapy with daclatasvir and asunaprevir achieved the same high rates of SVR24 in HCV elderly patients without more adverse events than in the non-elderly patients.
Biwa salmon,Oncorhynchus masou rhodurus,is endemic to Lake Biwa,and is considered one of the tastiest fishes among ***,aquaculture of this species is still in its ***,we conducted the present study to develop eco-frie...
详细信息
Biwa salmon,Oncorhynchus masou rhodurus,is endemic to Lake Biwa,and is considered one of the tastiest fishes among ***,aquaculture of this species is still in its ***,we conducted the present study to develop eco-friendly feed for Biwa salmon *** salmon(1.5 year-old,Samegai strain,initial mean body wt.277g) were reared in FRP tanks(1mt ton) and also in concrete ponds for 3 *** were fed either LP feed(low-phosphorus (P),fish meal-free diet;total P 0.73%,CP 39%,fat 16%) or control feed(commercial feed for Masu salmon;total P 1.61%,CP 45%,fat 6%) once daily to apparent satiation. Availability of dietary P was determined in vivo in separate *** groups of fish showed comparable feed consumption on an energy basis;however,toward the end of feeding duration feed intake decreased due to sexual *** mean body wt was 370g and 392g for LP and control groups,respectively(p>0.05).Both groups of fish showed similar feed efficiency (48-61%).Carcass P content was similar for both groups of fish,and was within a normal range. Fat content of fish fillets was 8.9%(LP) and 7.6%(control)(p0.05).The mRNA expression of phosphate-transporter(NaPi2b) in the colon was higher in control than LP fish (p0.05).Effluent P concentration was 10.7-18.2ppb in LP tanks,and 23.8-35.9ppb in control tanks(p<0.05).However,using a stagnant water system,net P excretion over 6 hours became Oppb in LP and 118.3ppb in control tanks (p<0.01).Apparent availability of dietary P was 50.8%(LP) and 28.8%(control).Estimated P
暂无评论